Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trials.

Le-Rademacher J, Kanwar R, Seisler D, Pachman DR, Qin R, Abyzov A, Ruddy KJ, Banck MS, Lavoie Smith EM, Dorsey SG, Aaronson NK, Sloan J, Loprinzi CL, Beutler AS.

Support Care Cancer. 2017 Nov;25(11):3537-3544. doi: 10.1007/s00520-017-3780-y. Epub 2017 Jun 20.

PMID:
28634656
2.

Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery.

Bryce AH, Egan JB, Borad MJ, Stewart AK, Nowakowski GS, Chanan-Khan A, Patnaik MM, Ansell SM, Banck MS, Robinson SI, Mansfield AS, Klee EW, Oliver GR, McCormick JB, Huneke NE, Tagtow CM, Jenkins RB, Rumilla KM, Kerr SE, Kocher JA, Beck SA, Fernandez-Zapico ME, Farrugia G, Lazaridis KN, McWilliams RR.

Oncotarget. 2017 Apr 18;8(16):27145-27154. doi: 10.18632/oncotarget.16057.

3.

A First-in-Human Phase I Study of a Bivalent MET Antibody, Emibetuzumab (LY2875358), as Monotherapy and in Combination with Erlotinib in Advanced Cancer.

Rosen LS, Goldman JW, Algazi AP, Turner PK, Moser B, Hu T, Wang XA, Tuttle J, Wacheck V, Wooldridge JE, Banck M.

Clin Cancer Res. 2017 Apr 15;23(8):1910-1919. doi: 10.1158/1078-0432.CCR-16-1418. Epub 2016 Oct 10.

4.

Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance).

Boora GK, Kanwar R, Kulkarni AA, Abyzov A, Sloan J, Ruddy KJ, Banck MS, Loprinzi CL, Beutler AS.

Cancer Med. 2016 Apr;5(4):631-9. doi: 10.1002/cam4.625. Epub 2016 Jan 14.

5.

Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance).

Boora GK, Kulkarni AA, Kanwar R, Beyerlein P, Qin R, Banck MS, Ruddy KJ, Pleticha J, Lynch CA, Behrens RJ, Züchner S, Loprinzi CL, Beutler AS.

J Neurol Sci. 2015 Oct 15;357(1-2):35-40. doi: 10.1016/j.jns.2015.06.056. Epub 2015 Jun 27.

6.

Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines.

Boora GK, Kanwar R, Kulkarni AA, Pleticha J, Ames M, Schroth G, Beutler AS, Banck MS.

Cancer Genet. 2015 Jul-Aug;208(7-8):374-81. doi: 10.1016/j.cancergen.2015.04.002. Epub 2015 Apr 14.

PMID:
26087898
7.

Plasticity of DNA methylation in a nerve injury model of pain.

Gölzenleuchter M, Kanwar R, Zaibak M, Al Saiegh F, Hartung T, Klukas J, Smalley RL, Cunningham JM, Figueroa ME, Schroth GP, Therneau TM, Banck MS, Beutler AS.

Epigenetics. 2015;10(3):200-12. doi: 10.1080/15592294.2015.1006493.

8.

RWDD3 and TECTA variants not linked to paclitaxel induced peripheral neuropathy in North American trial Alliance N08C1.

Kulkarni AA, Boora G, Kanwar R, Ruddy KJ, Banck MS, Le-Lindqwister N, Therneau TM, Loprinzi CL, Beutler AS.

Acta Oncol. 2015;54(8):1227-9. doi: 10.3109/0284186X.2014.985388. Epub 2014 Dec 31. No abstract available.

9.

Community-driven development for computational biology at Sprints, Hackathons and Codefests.

Möller S, Afgan E, Banck M, Bonnal RJ, Booth T, Chilton J, Cock PJ, Gumbel M, Harris N, Holland R, Kalaš M, Kaján L, Kibukawa E, Powel DR, Prins P, Quinn J, Sallou O, Strozzi F, Seemann T, Sloggett C, Soiland-Reyes S, Spooner W, Steinbiss S, Tille A, Travis AJ, Guimera R, Katayama T, Chapman BA.

BMC Bioinformatics. 2014;15 Suppl 14:S7. doi: 10.1186/1471-2105-15-S14-S7. Epub 2014 Nov 27.

10.

Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy.

Beutler AS, Kulkarni AA, Kanwar R, Klein CJ, Therneau TM, Qin R, Banck MS, Boora GK, Ruddy KJ, Wu Y, Smalley RL, Cunningham JM, Le-Lindqwister NA, Beyerlein P, Schroth GP, Windebank AJ, Züchner S, Loprinzi CL.

Ann Neurol. 2014 Nov;76(5):727-37. doi: 10.1002/ana.24265. Epub 2014 Sep 17.

11.

[There are more male than female patients within intensive care. But it is still unclear whether there are gender inequalities in Swedish intensive care or not].

Banck M, Walther S, Karlström G, Nolin T, Sjöberg F, Samuelsson C.

Lakartidningen. 2014 Feb 25;111(9-10):388-90. Swedish. No abstract available.

12.

Advances in small bowel neuroendocrine neoplasia.

Banck MS, Beutler AS.

Curr Opin Gastroenterol. 2014 Mar;30(2):163-7. doi: 10.1097/MOG.0000000000000043. Review.

13.

Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.

Francis JM, Kiezun A, Ramos AH, Serra S, Pedamallu CS, Qian ZR, Banck MS, Kanwar R, Kulkarni AA, Karpathakis A, Manzo V, Contractor T, Philips J, Nickerson E, Pho N, Hooshmand SM, Brais LK, Lawrence MS, Pugh T, McKenna A, Sivachenko A, Cibulskis K, Carter SL, Ojesina AI, Freeman S, Jones RT, Voet D, Saksena G, Auclair D, Onofrio R, Shefler E, Sougnez C, Grimsby J, Green L, Lennon N, Meyer T, Caplin M, Chung DC, Beutler AS, Ogino S, Thirlwell C, Shivdasani R, Asa SL, Harris CR, Getz G, Kulke M, Meyerson M.

Nat Genet. 2013 Dec;45(12):1483-6. doi: 10.1038/ng.2821. Epub 2013 Nov 3.

14.

The genomic landscape of small intestine neuroendocrine tumors.

Banck MS, Kanwar R, Kulkarni AA, Boora GK, Metge F, Kipp BR, Zhang L, Thorland EC, Minn KT, Tentu R, Eckloff BW, Wieben ED, Wu Y, Cunningham JM, Nagorney DM, Gilbert JA, Ames MM, Beutler AS.

J Clin Invest. 2013 Jun;123(6):2502-8. doi: 10.1172/JCI67963. Epub 2013 May 15.

15.

Diametrically opposite methylome-transcriptome relationships in high- and low-CpG promoter genes in postmitotic neural rat tissue.

Hartung T, Zhang L, Kanwar R, Khrebtukova I, Reinhardt M, Wang C, Therneau TM, Banck MS, Schroth GP, Beutler AS.

Epigenetics. 2012 May;7(5):421-8. doi: 10.4161/epi.19565. Epub 2012 May 1.

16.

Open Babel: An open chemical toolbox.

O'Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR.

J Cheminform. 2011 Oct 7;3:33. doi: 10.1186/1758-2946-3-33.

17.

p53-induced growth arrest is regulated by the mitochondrial SirT3 deacetylase.

Li S, Banck M, Mujtaba S, Zhou MM, Sugrue MM, Walsh MJ.

PLoS One. 2010 May 5;5(5):e10486. doi: 10.1371/journal.pone.0010486.

18.

mRNA-seq with agnostic splice site discovery for nervous system transcriptomics tested in chronic pain.

Hammer P, Banck MS, Amberg R, Wang C, Petznick G, Luo S, Khrebtukova I, Schroth GP, Beyerlein P, Beutler AS.

Genome Res. 2010 Jun;20(6):847-60. doi: 10.1101/gr.101204.109. Epub 2010 May 7.

19.
20.

Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS.

Barradas M, Anderton E, Acosta JC, Li S, Banito A, Rodriguez-Niedenführ M, Maertens G, Banck M, Zhou MM, Walsh MJ, Peters G, Gil J.

Genes Dev. 2009 May 15;23(10):1177-82. doi: 10.1101/gad.511109.

21.

The ZNF217 oncogene is a candidate organizer of repressive histone modifiers.

Banck MS, Li S, Nishio H, Wang C, Beutler AS, Walsh MJ.

Epigenetics. 2009 Feb 16;4(2):100-6. Epub 2009 Feb 23.

22.

Sensory neuron targeting by self-complementary AAV8 via lumbar puncture for chronic pain.

Storek B, Reinhardt M, Wang C, Janssen WG, Harder NM, Banck MS, Morrison JH, Beutler AS.

Proc Natl Acad Sci U S A. 2008 Jan 22;105(3):1055-60. doi: 10.1073/pnas.0708003105. Epub 2008 Jan 22.

23.

Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation.

Kremer-Tal S, Narla G, Chen Y, Hod E, DiFeo A, Yea S, Lee JS, Schwartz M, Thung SN, Fiel IM, Banck M, Zimran E, Thorgeirsson SS, Mazzaferro V, Bruix J, Martignetti JA, Llovet JM, Friedman SL.

J Hepatol. 2007 Apr;46(4):645-54. Epub 2006 Nov 27.

24.

KLF6 degradation after apoptotic DNA damage.

Banck MS, Beaven SW, Narla G, Walsh MJ, Friedman SL, Beutler AS.

FEBS Lett. 2006 Dec 22;580(30):6981-6. Epub 2006 Nov 13.

25.
26.

Intrathecal long-term gene expression by self-complementary adeno-associated virus type 1 suitable for chronic pain studies in rats.

Storek B, Harder NM, Banck MS, Wang C, McCarty DM, Janssen WG, Morrison JH, Walsh CE, Beutler AS.

Mol Pain. 2006 Jan 30;2:4.

27.

Intrathecal gene transfer by adeno-associated virus for pain.

Beutler AS, Banck MS, Walsh CE, Milligan ED.

Curr Opin Mol Ther. 2005 Oct;7(5):431-9. Review.

PMID:
16248278
28.

Krüppel-like factor-6 promotes preadipocyte differentiation through histone deacetylase 3-dependent repression of DLK1.

Li D, Yea S, Li S, Chen Z, Narla G, Banck M, Laborda J, Tan S, Friedman JM, Friedman SL, Walsh MJ.

J Biol Chem. 2005 Jul 22;280(29):26941-52. Epub 2005 May 25.

29.

Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1.

Benzeno S, Narla G, Allina J, Cheng GZ, Reeves HL, Banck MS, Odin JA, Diehl JA, Germain D, Friedman SL.

Cancer Res. 2004 Jun 1;64(11):3885-91.

30.

Tumor gene therapy made easy: allogeneic major histocompatibility complex in the C6 rat glioma model.

Beutler AS, Banck MS, Wedekind D, Hedrich HJ.

Hum Gene Ther. 1999 Jan 1;10(1):95-101.

PMID:
10022534
31.

Curing rat glioblastoma: immunotherapy or graft rejection?

Beutler AS, Banck MS, Aguzzi A.

Science. 1997 Apr 4;276(5309):20-1. No abstract available.

PMID:
9122700
32.

Retrovirus-mediated expression of an artificial beta-endorphin precursor in primary fibroblasts.

Beutler AS, Banck MS, Bach FW, Gage FH, Porreca F, Bilsky EJ, Yaksh TL.

J Neurochem. 1995 Feb;64(2):475-81.

PMID:
7830038

Supplemental Content

Support Center